Final results of a phase III randomized study of concurrent weekly cisplatin-RT versus RT alone in locoregionally advanced nasopharyngeal carcinoma (NPC).

被引：0
|
作者：
Chan, AT
Ngan, R
Teo, P
Leung, SF
Yiu, HY
Yeo, W
Mok, T
Cheung, FY
Kwan, W
Zee, B
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5523
引用
收藏
页码：493S / 493S
页数：1
相关论文
共 50 条
  • [1] A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel and cisplatin in advanced nasopharyngeal carcinoma (NPC).
    Chan, AT
    Hui, EP
    Ma, B
    Leung, SF
    King, A
    Mo, F
    Lai, M
    Yu, KH
    Kwan, WH
    Zee, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 511S - 511S
  • [2] A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
    Frikha, M.
    Auperin, A.
    Tao, Y.
    Elloumi, F.
    Toumi, N.
    Blanchard, P.
    Lang, P.
    Sun, S.
    Racadot, S.
    Thariat, J.
    Alfonsi, M.
    Tuchais, C.
    Cornely, A.
    Moussa, A.
    Guigay, J.
    Daoud, J.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 731 - 736
  • [3] Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced nasopharyngeal carcinoma
    Isobe K.
    Uno T.
    Aruga T.
    Kawakami H.
    Ueno N.
    Hanazawa T.
    Okamoto Y.
    Ito H.
    International Journal of Clinical Oncology, 2005, 10 (3) : 201 - 203
  • [4] Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma
    Wen, Linchun
    You, Chuanwen
    Lu, Xiyan
    Zhang, Longzhen
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 687 - 691
  • [5] Weekly docetaxel concurrent chemoradiotherapy versus cisplatin in locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis
    Liao, J. F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma
    Yu, Hong-Sheng
    Wang, Xin
    Song, Ai-Qin
    Liu, Ning
    Zhang, Wei
    Yu, Li
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3961 - 3965
  • [7] Preliminary Results of a Phase III Randomized Study Comparing Neoadjuvant Chemotherapy with Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Xu, T.
    Hu, C.
    He, X.
    Zhu, G.
    Wu, Y.
    Ying, H.
    Kong, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S4 - S4
  • [8] Gemcitabine and cisplatin (GP) induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) versus CCRT alone in locoregionally advanced nasopharyngeal carcinoma (NPC): A phase 3, multicenter, randomized controlled trial.
    Ma, Jun
    Zhang, Yuan
    Sun, Ying
    Xie, Fangyun
    Hu, Weihan
    Hu, Guoqing
    Zhang, Ning
    Yang, Kun-Yu
    Zhu, Xiaodong
    Jin, Feng
    Cheng, Zhi-Bin
    Shi, Mei
    Han, Fei
    Tian, Ye
    Sun, Yan
    Mo, Hao-Yuan
    Li, Jin-Gao
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Dose Delivery Analysis of Weekly Versus 3-Weekly Cisplatin Concurrent With Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
    Jagdis, Amanda
    Laskin, Janessa
    Hao, Desiree
    Hay, John
    Wu, Jonn
    Ho, Cheryl
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 63 - 69
  • [10] Triweekly versus weekly cisplatin concurrent with radiotherapy in locally advanced nasopharyngeal carcinoma
    Lan, M.
    Wu, S.
    Han, F.
    Deng, M.
    Chen, C.
    Huang, Y.
    Duan, Z.
    Liao, J.
    Tian, L.
    Zheng, L.
    Lu, T.
    ANNALS OF ONCOLOGY, 2016, 27
12345